美国持久性机械循环支持装置使用的地理区域与少数族裔差异
本研究基于INTERMACS与Medicare联合数据集,分析2008至2014年美国232个中心16,331例持久性机械循环支持装置(MCSD)植入的地理与种族差异。各UNOS区域年植入率均显著上升,少数族裔在几乎所有区域植入率高于白人,部分区域相对增幅显著更大,原因尚不明确。
要点
- 各UNOS区域MCSD年植入率均显著上升,绝对增幅范围5.3-16.4/百万人口。
- 2014年UNOS第7区域绝对植入率最高(20.9/百万人口),第11区域相对增幅最大(430.5%)。
- 少数族裔在几乎所有UNOS区域及所有年份的MCSD植入率均高于白人。
核心结论
- 美国持久性MCSD植入率存在地理差异,且白人与少数族裔之间的植入率模式不同。
- 差异原因未知,可能反映疾病负担差异或心脏移植可及性差异,需进一步研究。
研究设计与样本
- 联合INTERMACS与Medicare数据集识别2008至2014年持久性MCSD植入病例。
- 使用美国人口普查数据及CDC WONDER数据库按年龄、种族和UNOS区域分层估算植入率。
主要发现
- 共16,331例患者在232个中心接受MCSD植入。
- 各UNOS区域年植入率(每百万人口)均显著上升,绝对增幅范围5.3-16.4。
- 2014年UNOS第7区域总体绝对植入率最高(20.9),第11区域相对增幅最大(430.5%)。
- 少数族裔在几乎所有UNOS区域及所有年份的MCSD植入率均高于白人。
- UNOS第2、3、6、7、8、9和11区域少数族裔相对白人MCSD植入相对增幅显著更大(P < .001)。
临床怎么用
- 心胸外科医生应关注MCSD植入率的地理与种族差异,评估本地患者可及性。
- 在转诊与筛选MCSD候选者时,需考虑可能存在的移植可及性差异。
局限性
- 差异原因无法从现有数据确定,可能受疾病负担或移植可及性等混杂因素影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Durable mechanical circulatory support device (MCSD) therapy has experienced rapid dissemination in the United States. Few studies have evaluated geographic patterns of its dissemination based upon patient characteristics that could identify potential variation in its application. METHODS: A combined Interagency Registry for Mechanically Assisted Circulatory Support and Medicare dataset identified durable MCSD implants from 2008 through 2014. MCSD implant rates were estimated using yearly US Census population data, estimated from the Centers for Disease Control and Prevention Wide-ranging Online Data for Epidemiologic Research database and stratified by age, race, and United Network for Organ Sharing (UNOS) region. RESULTS: Overall, 16,331 patients received an MCSD implant from 232 unique centers. Annual MCSD implant rate (per 1 million population) significantly increased in each UNOS region (absolute range of increase, 5.3-16.4) with UNOS Region 7 demonstrating the highest overall absolute rate (20.9) in 2014 and UNOS Region 11 demonstrating the greatest relative increase in rate (430.5%). Geographical differences in the rate of MCSD implants were observed among whites and minorities with higher rates of MCSD implants observed for minorities for nearly all UNOS regions across all years. Significantly greater relative increases in MCSD implants for minorities compared with whites were observed within UNOS Regions 2, 3, 6, 7, 8, 9, and 11 (P < .001). CONCLUSIONS: Geographical differences exist in rates of MCSD implantation among whites and minorities. The reasons for these differences are unknown, but may reflect underlying differences in disease burden or disparities in access to heart transplantation and warrant further study.
引用
- Bourque JL, Liang Q, Pagani FD, et al. Durable mechanical circulatory support device use in the United States by geographic region and minority status. J Thorac Cardiovasc Surg. 2019. PMID: 31761344. doi:10.1016/j.jtcvs.2019.09.182
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。